With this aim, Fallon et al selleck chem described how infusion of transforming growth factor α (TGFα) into the striatal parenchyma resulted in an “in vivo induction of massive proliferation, directed migration, and differentiation of neural cells” from the subventricular zone, with positive functional effects in a rat model of PD.98 This potentially very interesting observation now awaits confirmation

by other independent research groups. Moreover, it was recently suggested that, there is a turnover #selleck screening library keyword# of DA neurons in the SNc of the adult, mouse and that, this turnover Inhibitors,research,lifescience,medical increases when the DA neurons are toxically injured by MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) treatment.99 Other workers have failed to find such a turnover normally ongoing in the adult SNc, but it has been shown that adult neural stem cells isolated from the SNc region have the potential to differentiate into neurons when grafted into neurogenic regions such as the hippocampus.100 Additional research will have to show whether or not similar results can be found in

humans. Conclusion The optimal source for transplantation is one of cells that can be efficiently Inhibitors,research,lifescience,medical and reproducibly produced at a reasonable cost in combination with showing predictable therapeutic efficacy after grafting. The cells should

require minimal genetic manipulation or modification Inhibitors,research,lifescience,medical by signaling molecules in culture media to properly differentiate into the required Inhibitors,research,lifescience,medical cell types. Furthermore, they should be nonproliferative after grafting, free of infectious elements, and immunologically compatible with the host. As reviewed in this article, research to develop transplant procedures is trying to fulfill these criteria. In contrast to the limitations of fetal cell sources, and to the cellularmolecular complexities of diverse NPCs, advances in the biology of blastula-derived ES cells suggest that this source may have important advantages over the others. However, to keep the expectations of stem cells from becoming unrealistic, it should Brefeldin_A probably be emphasized to clinicians and to patients and their families not to expect the clinical outcome using stem cell-derived DA neurons to be fundamentally “better” than what has already been achieved in the best cases using fetal DA neurons. After all, stem cells are basically just a way of obtaining a more practical and reliable source of the same type of neuron that has already been tried in clinics.